Comprehensive studies on the relationships of depression and carnitine metabolism can lend support to the diagnosis and treatment of other psychiatric diseases such as BD and schizophrenia, so as to further study the similarities and differences of carnitine metabolism in psychiatric diseases
Neuron 110 , 34583483 (2022)
Food and Drug Administration recently announced plans to crack down on the active pharmaceutical ingredients used in glucagonlike peptide 1 (GLP-1) drugs produced at compounding pharmacies, which make customized medications when FDA-approved drugs are unavailable
As Healio previously reported, the SURMOUNT-1 3-year trial assessed the efficacy of tirzepatide (Mounjaro/Zepbound, Eli Lilly) on body weight and glycemia for adults with prediabetes who participated in SURMOUNT-1
we see ourselves as partners in your work
However, GLP-1 peptide agonists currently administered by injection except for oral semaglutide, has stimulated the search for more convenient and orally administered drugs